Shots: BMS to acquire all the outstanding shares of MyoKardia’s common stock for $225.00/ share in cash, making a total deal value of ~$13.1B. The transaction is expected to be […]readmore
Tags : Acquire
Shots: Medtronic acquires Avenu Medical for its Percutaneous Fistula Creation Technology that will foster Medtronic’s peripheral vascular access portfolio and improves outcomes for patients with ESRD undergoing dialysis. The acquisition […]readmore
Shots: Illumina to acquire GRAIL in cash & stock transaction for $8B including ~$3.5B in cash and $4.5B in shares of Illumina common stock. Illumina founded GRAIL in 2016 and […]readmore
Shots: Gilead to acquire Immunomedics for $88.00/ share representing a 108% premium to Immunomedics’ closing price on Sept 11, 2020, making a total deal value $21B. The transaction is expected […]readmore
Shots: Mylan signed an agreement to acquire the related IP and commercialization rights of Aspen’s thrombosis business in the EU for $758.59M which include ~$311.08M as up front and ~$447.46 […]readmore
Shots: Grifols to acquire the remaining stock of Alkahest for a total value of $146M. The transaction is expected to be close in H1’21 The acquisition will enhance discovery, research, […]readmore
Shots: Nestle to acquire all outstanding shares of Aimmune’s common stock for $34.50/share in cash, making a total deal value as $2.6B, representing a 174% premium to Aimmune’s closing share […]readmore
Shots: Ionis will acquire all the outstanding shares of Akcea common stock it does not already own, ~24%, for $18.15/share in cash, making a total deal value as $500M. The […]readmore
Shots: Philips will acquire Intact Vascular for $275M up front and deferred payments of $85M upon completion of the transaction. The transaction is expected to be completed in Q3’20 The […]readmore
Shots: Forbius will receive up front and milestones while BMS will acquire Forbius’s TGF-beta program, including the lead investigational asset, AVID200. The transaction is expected to be closed in Q4’20 […]readmore